Vasopressine in Septic Shock Management


  • Iswandi Darwis Fakultas Kedokteran Universitas Lampung
  • Rizka Humardewayanti Asdie Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan Universitas Gadjah Mada
  • Neema Putri Prameswari Universitas Lampung



sepsis, syok septik, vasopressin


Sepsis is a systemic inflammatory response caused by an infection, which can involve multiple organs. Sepsis and multiple organ dysfunction syndrome (MODS) are the main causes of death in the intensive care unit of a hospital. In sepsis, septic shock, defined as sepsis-induced persistent hypotension despite adequate fluid resuscitation causing tissue hypoperfusion, can occur. Norepinephrine and dopamine are the vasopressors of choice for initial treatment septic shock, but the use of high-dose catecholamine vasopressors can cause adrenergic side effects that can increase mortality. Therefore, a septic shock patient with increased heart rate, it is necessary to use a vasopressor that does not cause adrenergic side effects. Vasopressin is a hormone secreted by the posterior pituitary. In hypotensive condition, vasopressin physiologically helps maintain blood pressure by acting as a potent vasoconstrictor. Vasopressin administration does not cause side effects caused by adrenergic stimulation such as increased tissue oxygen demand, decreased renal and mesenteric flow, increased pulmonary resistance and arrhythmias. This literature review also discusses the effects of vasopressin on blood pressure, the cardiovascular system, the immune system, the coagulation system, the respiratory system, the urinary system and the central nervous system in patients with septic shock.


Impaired Phagocytosis and Calcium Signaling. SHOCK,Vol. 30, No. 6, pp. 618Y622, 2008.

Hermawan, AG. 2014. Sepsis dalam Buku Ajar Ilmu Penyakit Dalam Jilid I edisi VI. Interna Publishing. Jakarta.

Chen, K., Pohan, HT. 2014. Penatalaksanaan Syok Septik dalam Buku Ajar Penyakit Dalam Jilid III edisi VI. Interna Publishing. Jakarta.

Dellinger, P., Levy, MM. Carlet, JM., Bion, JB., Parker, MM., Jaeschke, R., Reinhart, K., Angus, DC, Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, JF., Gerlach, H., Harvey, MRN., Marini, JJ., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, BT., Townsend, S., Vender, JS., Zimmerman, JL., Vincent, JL. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. International Surviving Sepsis Campaign Guidelines Committee

Neto, AS., Júnior, APN., Cardoso, SO., Manetta, JA., Pereira, VGM., Espósito, DC., Damasceno, MCT., Russell, JA. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Serpa Netoet al. Critical Care. 2012,16: R154

Patel, BM., Chittock, DR., Russell, JA., Walley, KR. Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock. Anesthesiology 2002; 96(3):576 – 82.

Spence, PA., Mason, B, 2003, Human Anatomy and Physiology, edisi kedua, The Benjanzin Cummings Publishing Company, Menlo Park

Russell, JA. Bench-to-bedside review: Vasopressin in the management of septic shock. Critical Care. 2011, 15:226.

Landry DW, Levin HR, Gallant EM, Ashton RC, Jr., Seo S, D’Alessandro D, Oz MC, Oliver JA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation1997, 95:1122-1125

Krismer, AC., Dünser, MW., Lindner, KH., Stadlbauer, KH., Mayr, VD., Lienhart, HG., Arntz, RH., Wenzel, V. Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature. Am J Cardiovasc Drugs. 2006;6(1):51-68.

Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., Grossman, A. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLOS ONE | DOI:10.1371/journal.pone.0129305. 2005

FernaÂndez, N., MartõÂnez, MA., GarcõÂa-Villalo, AL., Monge, L., DieÂguez, G. Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V1and V2receptors and nitric oxide. British Journal of Pharmacology (2001)

Martha, E., O’Donnell, Duong, V., Suvatne, J., Foroutan, S., Johnson, DM. Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1receptor and [Ca] dependent. Am J Physiol Cell Physiol289: C283–C292, 2005



How to Cite

Iswandi Darwis, Rizka Humardewayanti Asdie, & Neema Putri Prameswari. (2022). Vasopressine in Septic Shock Management. Medical Profession Journal of Lampung, 11(3), 312-319.